Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
SOPH Sophia Genetics
2.940-0.060-2.00%
Trading Session
02/02 14:03 ET
High
3.080
Open
3.080
Turnover
86.34K
Low
2.900
Pre Close
3.000
Volume
28.84K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Poseida Therapeutics (NASDAQ:PSTX) & SOPHiA GENETICS (NASDAQ:SOPH) Head to Head Survey
SOPHiA GENETICS (NASDAQ:SOPH – Get Rating) and Poseida Therapeutics (NASDAQ:PSTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two compa
Comparing Exscientia (NASDAQ:EXAI) & SOPHiA GENETICS (NASDAQ:SOPH)
Exscientia (NASDAQ:EXAI – Get Rating) and SOPHiA GENETICS (NASDAQ:SOPH – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses base
Head-To-Head Review: SOPHiA GENETICS (NASDAQ:SOPH) Vs. Poseida Therapeutics (NASDAQ:PSTX)
SOPHiA GENETICS (NASDAQ:SOPH – Get Rating) and Poseida Therapeutics (NASDAQ:PSTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two compan
SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference
SOPHiA GENETICS (NASDAQ:SOPH) Now Covered by Analysts at BTIG Research
BTIG Research started coverage on shares of SOPHiA GENETICS (NASDAQ:SOPH – Get Rating) in a research note issued to investors on Tuesday, The Fly reports. The brokerage issued a buy rating and a $6.0
BTIG Starts SOPHiA GENETICS at Buy With $6 Price Target
10:00 AM EST, 01/03/2023 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co
SOPHiA GENETICS Price Target Announced at $6.00/Share by BTIG
Sophia Genetics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/03/2023 191.26% BTIG → $6 Initiates Coverage On → Buy 11/23/2022 -2.91% Credit Suisse → $2 Initiates Co
BTIG Initiates Coverage On Sophia Genetics With Buy Rating, Announces Price Target of $6
BTIG analyst Mark Massaro initiates coverage on Sophia Genetics (NASDAQ:SOPH) with a Buy rating and announces Price Target of $6.
Sophia Genetics Initiated With a Buy at BTIG
Company Overview
More
SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.
CEO： Dr. Jurgi Camblong, M.B.A.
Market： NASDAQ
Listing Date： 07/23/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet